Shin Poong Pharm to present innovative stroke drug ‘SP-8203’ at BIO USA

Published: 2018-05-29 22:17:51

Updated: 2018-05-29 22:17:51

Shin Poong Pharm(CEO Jae-Man Yoo) will participate in ‘2018 BIO International Convention,’ the world’s largest biopharmaceutical convention held in Boston between 4 and 7 June, and will announce clinical results about its innovative new stroke drug ‘SP-8203’ and results about new drugs that the company is currently developing.

CEO Jae-Man Yoo who will appear on the platform on 6 June will give...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.